These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31147936)

  • 1. A SIINFEKL-Based System to Measure MHC Class I Antigen Presentation Efficiency and Kinetics.
    Dersh D; Yewdell JW; Wei J
    Methods Mol Biol; 2019; 1988():109-122. PubMed ID: 31147936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases.
    Compagnone M; Fruci D
    Methods Mol Biol; 2019; 1988():45-57. PubMed ID: 31147931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitating MHC Class I Ligand Production and Presentation Using TCR-Like Antibodies.
    Dolan BP
    Methods Mol Biol; 2019; 1988():149-157. PubMed ID: 31147939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous viral antigen processing generates peptide-specific MHC class I cell-surface clusters.
    Lu X; Gibbs JS; Hickman HD; David A; Dolan BP; Jin Y; Kranz DM; Bennink JR; Yewdell JW; Varma R
    Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15407-12. PubMed ID: 22949678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of exogenous antigens for presentation by class I MHC molecules involves post-Golgi peptide exchange influenced by peptide-MHC complex stability and acidic pH.
    Chefalo PJ; Harding CV
    J Immunol; 2001 Aug; 167(3):1274-82. PubMed ID: 11466343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Flow Cytometry-Based Approach to Unravel Viral Interference with the MHC Class I Antigen Processing and Presentation Pathway.
    Praest P; de Buhr H; Wiertz EJHJ
    Methods Mol Biol; 2019; 1988():187-198. PubMed ID: 31147941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical biology of antigen presentation by MHC molecules.
    van Kasteren SI; Overkleeft H; Ovaa H; Neefjes J
    Curr Opin Immunol; 2014 Feb; 26():21-31. PubMed ID: 24556397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
    Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
    J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of endogenous antigen processing by delivery of an intact protein into cells.
    Fu H; Ding J; Flutter B; Gao B
    J Immunol Methods; 2008 Jun; 335(1-2):90-7. PubMed ID: 18406420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical Analysis of Naturally Processed Antigenic Peptides Presented by MHC Class I Molecules.
    Kanaseki T; Shastri N
    Methods Mol Biol; 2019; 1988():101-108. PubMed ID: 31147935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Studies of MHC Class I Peptide Loading and Exchange.
    Bouvier M
    Methods Mol Biol; 2019; 1988():71-81. PubMed ID: 31147933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
    Stevanović S; Schild H
    Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
    Nelde A; Kowalewski DJ; Stevanović S
    Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brucella Peptide Cross-Reactive Major Histocompatibility Complex Class I Presentation Activates SIINFEKL-Specific T Cell Receptor-Expressing T Cells.
    Harms JS; Khan M; Hall C; Splitter GA; Homan EJ; Bremel RD; Smith JA
    Infect Immun; 2018 Jul; 86(7):. PubMed ID: 29735518
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.
    Yang Y; Sempé P; Peterson PA
    Immunol Res; 1996; 15(3):208-33. PubMed ID: 8902577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
    Palmer AL; Dolan BP
    PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.